Neurocrine Biosciences, Inc <NBIX.O>: Stifel Raises Target Price to $215 From $188
NBIX•Related News
Garden Stage FY26 net loss widens to US$13.84 million; revenue rises 33.2% to US$7.28 million
GSIW•
KB Home opens Aurora community at One Lake in Fairfield, California, priced from $590,000s
KBH•
Franklin Templeton posts July distributions for five closed-end funds, led by BWG at $0.08/share
BEN•
Coinbase shares take hit on quarterly loss, analysts back diversification strategy
COIN•
Space-Eyes And McKinley Acquisition Corp. Announce Definitive Business Combination Agreement To Deliver Ai-Driven Counter Drone Technology And Geospatial Intelligence Worldwide
MKLY•